TVTX
Travere Therapeutics Inc
50.40$
-0.4%
vs. previous close
Closing price · As of: Oct 30, 2026
Ownership
Ownership Structure
Who owns Travere Therapeutics Inc (TVTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.9% of the shares are freely tradable; institutional investors hold 113.4%.
Institutional ownership
?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
113.4%
Insiders
?Share of the stock held by the executives, founders and major shareholders of the company itself.
0.8%
Float
?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
98.9%
Short % of float
?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
15.1%
Shares Outstanding
?Total number of shares issued. Price times share count gives market cap.
93Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HHG PLC | 12.11 | 11,419,586 | +8.6 | 03/31/2026 |
| Jupiter Topco LLC | 12.01 | 11,324,191 | +0.0 | 06/30/2026 |
| BlackRock Inc | 8.51 | 8,020,663 | +2.9 | 06/30/2026 |
| FMR Inc | 7.53 | 7,096,614 | -35.3 | 06/30/2026 |
| Bank of America Corp | 4.85 | 4,568,341 | +239.6 | 06/30/2026 |
| State Street Corp | 4.52 | 4,256,224 | -14.2 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.36 | 4,108,694 | +1.6 | 06/30/2026 |
| Perceptive Advisors LLC | 3.98 | 3,752,574 | -9.4 | 06/30/2026 |
| Delaware Management Holdings Inc | 2.98 | 2,812,514 | -14.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.14 | 2,962,690 | +0.3 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 432,886 | 21,817,454 $ | Oct 15, 2026 | direct |
| Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | 117,066 | 5,900,126 $ | Sep 17, 2026 | direct |
| Reed Elizabeth E | Chief Legal Officer and GC | 105,389 | 5,311,606 $ | Sep 15, 2026 | direct |
| Inrig Jula | EVP, Head of R&D & CMO | 100,491 | 5,064,746 $ | Sep 15, 2026 | direct |
| Rote William E. | Chief Research Officer | 98,197 | 4,949,129 $ | Sep 16, 2026 | direct |
| Meckler Jeffrey A | Director | 91,500 | 4,611,600 $ | Sep 10, 2026 | direct |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 87,508 | 4,410,403 $ | Sep 15, 2026 | direct |
| Lyons Gary A | Director | 61,500 | 3,099,600 $ | Aug 18, 2026 | direct |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 42,353 | 2,134,591 $ | Sep 15, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 78,400 | 55.02 | 4,313,403 |
| Oct 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 37,270 | 54.20 | 2,020,023 |
| Oct 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 128,065 | 52.97 | 6,783,244 |
| Oct 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Other | 200,000 | 8.93 | 1,786,000 |
| Oct 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Other | 43,735 | 26.88 | 1,175,597 |
| Sep 17, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 8,282 | 65.07 | 538,917 |
| Sep 17, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Other | 8,282 | 22.40 | 185,517 |
| Sep 17, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 6,802 | 64.95 | 441,795 |
| Sep 17, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 101,691 | 64.59 | 6,567,876 |
| Sep 17, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Other | 108,493 | 23.34 | 2,532,227 |
| Sep 16, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 79,113 | 63.65 | 5,035,906 |
| Sep 16, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 93,604 | 63.25 | 5,920,182 |
| Sep 16, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Other | 17,717 | 26.88 | 476,233 |
| Sep 16, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Other | 55,000 | 15.46 | 850,300 |
| Sep 16, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Other | 100,000 | 11.25 | 1,125,000 |
| Sep 16, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 96,125 | 63.64 | 6,117,289 |
| Sep 16, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 99,716 | 63.26 | 6,307,964 |
| Sep 16, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Other | 195,841 | 23.34 | 4,570,929 |
| Sep 16, 2026 | Rote William E. | Chief Research Officer | Sell | 47,746 | 63.61 | 3,037,247 |
| Sep 16, 2026 | Rote William E. | Chief Research Officer | Sell | 65,104 | 63.12 | 4,109,397 |
| Sep 16, 2026 | Rote William E. | Chief Research Officer | Other | 57,500 | 26.88 | 1,545,600 |
| Sep 16, 2026 | Rote William E. | Chief Research Officer | Other | 55,000 | 15.46 | 850,300 |
| Sep 16, 2026 | Rote William E. | Chief Research Officer | Other | 350 | 17.96 | 6,286 |
| Sep 15, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 400 | 65.31 | 26,124 |
| Sep 15, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 1,900 | 63.69 | 121,004 |
| Sep 15, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 20,735 | 62.61 | 1,298,175 |
| Sep 15, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 27,473 | 62.00 | 1,703,241 |
| Sep 15, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Other | 20,000 | 17.44 | 348,800 |
| Sep 15, 2026 | Inrig Jula | EVP, Head of R&D & CMO | Sell | 400 | 65.31 | 26,124 |
| Sep 15, 2026 | Inrig Jula | EVP, Head of R&D & CMO | Sell | 1,600 | 63.69 | 101,896 |
| Sep 15, 2026 | Inrig Jula | EVP, Head of R&D & CMO | Sell | 17,284 | 62.62 | 1,082,397 |
| Sep 15, 2026 | Inrig Jula | EVP, Head of R&D & CMO | Sell | 25,390 | 62.02 | 1,574,604 |
| Sep 15, 2026 | Inrig Jula | EVP, Head of R&D & CMO | Other | 32,395 | 8.93 | 289,287 |
| Sep 15, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | 300 | 63.66 | 19,099 |
| Sep 15, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | 800 | 62.85 | 50,278 |
| Sep 15, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | 4,275 | 62.14 | 265,627 |
| Sep 15, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Other | 1,625 | 20.46 | 33,248 |
| Sep 15, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Other | 1,250 | 22.40 | 28,000 |
| Sep 15, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Other | 2,500 | 27.50 | 68,750 |
| Sep 15, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 1,431 | 65.31 | 93,458 |
| Sep 15, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 1,400 | 63.65 | 89,113 |
| Sep 15, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 27,421 | 62.59 | 1,716,379 |
| Sep 15, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Sell | 71,938 | 62.05 | 4,463,875 |
| Sep 15, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Other | 36,526 | 8.93 | 326,177 |
| Sep 15, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Other | 1,381 | 22.40 | 30,934 |
| Sep 15, 2026 | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | Other | 39,283 | 26.88 | 1,055,927 |
| Sep 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 270 | 65.31 | 17,634 |
| Sep 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 3,102 | 63.64 | 197,422 |
| Sep 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 28,796 | 62.66 | 1,804,222 |
| Sep 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 63,498 | 61.99 | 3,936,527 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.